Manulife (Manufacturers Life Insurance)
AVDL

Manulife (Manufacturers Life Insurance)’s Avadel Pharmaceuticals AVDL Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-39,947
Closed -$861K – 2817
2025
Q4 		$861K Sell
39,947
-5,621
-12% -$109K ﹤0.01% 1927
2025
Q3 		$696K Buy
45,568
+6,981
+18% +$90.8K ﹤0.01% 2052
2025
Q2 		$341K Sell
38,587
-2,792
-7% -$24.5K ﹤0.01% 2335
2025
Q1 		$324K Sell
41,379
-14,773
-26% -$124K ﹤0.01% 2314
2024
Q4 		$590K Sell
56,152
-247
-0.4% -$3K ﹤0.01% 2159
2024
Q3 		$740K Buy
56,399
+14,420
+34% +$220K ﹤0.01% 2077
2024
Q2 		$590K Buy
+41,979
New +$684K ﹤0.01% 2142
2018
Q3 		– Sell
-206
Closed -$1K – 2991
2018
Q2 		$1K Buy
206
+19
+10% +$133 ﹤0.01% 4236
2018
Q1 		$1K Buy
187
+24
+15% +$211 ﹤0.01% 4262
2017
Q4 		$1K Buy
163
+23
+16% +$216 ﹤0.01% 4253
2017
Q3 		$1K Sell
140
-3
-2% -$29 ﹤0.01% 4147
2017
Q2 		$2K Buy
143
+128
+853% +$1.28K ﹤0.01% 4105
2017
Q1 		$0 Sell
15
-3
-17% -$30 ﹤0.01% 4195
2016
Q4 		$0 Buy
+18
New +$198 ﹤0.01% 4343

Other funds holding AVDL

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s AVDL Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 39,947 shares — an estimated $861K sold.

Manulife (Manufacturers Life Insurance) first reported a position in AVDL in Q4 2016 and held it in 14 quarters. The position peaked at $861K in Q4 2025. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 39,947 Avadel Pharmaceuticals shares in Q1 2026, an estimated $861K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Avadel Pharmaceuticals in Q4 2016 and held it in 14 quarters.
  • Manulife (Manufacturers Life Insurance)'s Avadel Pharmaceuticals position peaked at $861K in Q4 2025.
  • 2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.